• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dev Ctries . Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patients

tetano

Editor, Senior Moderator
J Infect Dev Ctries


. 2022 Mar 31;16(3):445-452.
doi: 10.3855/jidc.15818.
Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patients


Imran Saglik[SUP] 1 [/SUP], Beyza Ener[SUP] 2 [/SUP], Halis Akalin[SUP] 3 [/SUP], Buşra Ozdemir[SUP] 4 [/SUP], Gokhan Ocakoglu[SUP] 5 [/SUP], Baris Yalcin[SUP] 6 [/SUP], Ugur Onal[SUP] 3 [/SUP], Ozge Aydin Guçlu[SUP] 7 [/SUP], Nilufer Aylin Acet Ozturk[SUP] 7 [/SUP], Ulku Tuzemen[SUP] 2 [/SUP], Ezgi Demirdogen[SUP] 7 [/SUP], Asli Gorek Dilektasli[SUP] 7 [/SUP], Harun Agca[SUP] 2 [/SUP], Esra Kazak[SUP] 3 [/SUP], Funda Coskun[SUP] 7 [/SUP], Yasemin Heper[SUP] 3 [/SUP], Melda Payaslioglu[SUP] 2 [/SUP], Dane Ediger[SUP] 7 [/SUP], Ahmet Ursavas[SUP] 7 [/SUP], Emel Yilmaz[SUP] 3 [/SUP], Cuneyt Ozakin[SUP] 2 [/SUP], Esra Uzaslan[SUP] 7 [/SUP], Mehmet Karadag[SUP] 7 [/SUP]



Affiliations

Abstract

Introduction: Our knowledge has gaps regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication levels and its association to severity of Coronavirus disease 2019 (COVID-19). The aim of this study was to investigate the association of SARS-CoV-2 viral load with disease severity and serum biomarkers in COVID-19 patients.
Methodology: Viral load was determined via cycle threshold (Ct) values of SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction (RT-PCR) in 214 adult patients. Ct values were compared with clinical severity, biochemical and hematological biomarkers.
Results: Clinical course of the disease was mild (49.1%), moderate (40.2%), and severe (10.7%). Median Ct value was 28.2 (IQR: 22.2-33.8) during the first week of the disease. Ct values were lower within five days after symptom onset [lowest Ct value on the third day (median: 24, IQR: 20.6-32.3)], but they increased significantly during the second and third weeks. No association was detected between admission Ct values and disease severity. Gender, age, co-morbidity, and mortality did not differ significantly in patients with low (≤ 25) and high (> 25) Ct values. White blood cell, neutrophil, platelet, and especially lymphocyte counts, were significantly lower in patients with low Ct values.
Conclusions: No definitive/clear correlation between SARS-CoV-2 viral load and severity and mortality was found in the studied COVID-19 patients. However, neutrophil, platelet, and especially lymphocyte count were significantly lower in patients with a high viral load.

Keywords: COVID-19; Ct value; SARS-CoV-2; lymphocyte; severity.
 
Back
Top Bottom